Safe Addiction Treatment for Pregnant Women in Kansas

Opioids: Medication-Assisted Treatment is Key

For opioid use, including pills, heroin, or fentanyl, the clinical approach during pregnancy almost always involves medication rather than a rapid taper to zero. This often surprises people who associate “detox” with immediate abstinence. However, during pregnancy, this traditional model can be harmful.

Current research and guidelines support this approach. The CDC recommends Medication for Opioid Use Disorder (MOUD) over tapering for pregnant women with OUD ³, and federal guidance advises against quickly stopping opioids ². KDHE’s guidance also states that OUD during pregnancy is best treated with methadone or buprenorphine, combined with counseling, recovery support, and prenatal care ¹.

In practice, this means a doctor will evaluate you and initiate a prescribed daily dose of methadone or buprenorphine. This stabilizes your body, reduces withdrawal symptoms, and quiets cravings, allowing both you and your baby to avoid the stress of fluctuating substance levels. SAMHSA highlights these medications as among the safest options for managing OUD during pregnancy because they prevent withdrawal and reduce cravings without the instability of nonmedical use ⁵.

Medically monitored detox for opioids during pregnancy focuses on stabilizing you on a medication regimen that ensures safety for both of you, integrating counseling and prenatal care around this foundation. If any program pressures you to discontinue MOUD against medical advice while pregnant, it’s a clear signal to seek care elsewhere.

Alcohol and Benzodiazepines: Inpatient Medical Detox is Essential

Alcohol and benzodiazepines (such as Xanax, Klonopin, Ativan, and Valium) present unique and severe risks during withdrawal. Withdrawal from these substances can induce seizures and, in severe cases, be fatal, regardless of pregnancy. During pregnancy, a seizure is also an obstetric emergency, making “just stop” the most dangerous advice possible.

Kansas perinatal screening guidance explicitly recommends inpatient 24-hour medical care for detoxification from alcohol, sedatives, and opioids ⁶. This means a supervised setting with nursing staff, physician oversight for withdrawal symptom management, and continuous vital-sign monitoring. This is not an outpatient program but requires inpatient care.

If you have been regularly consuming alcohol or benzodiazepines for an extended period, do not attempt to stop at home. It is safer to enter care while still using. Clinicians are prepared for this and have protocols and medications to ensure a safe withdrawal in a controlled environment, with your pregnancy closely monitored. The fear of seeking help is often greater than the reality of the process. A supervised medical detox for alcohol or benzodiazepines is a structured, short-term stay designed to navigate the physical dangers, allowing you to begin the longer journey of recovery safely.

Stimulants and Polysubstance Use: Monitored Stabilization

Stimulants like methamphetamine and cocaine typically do not cause the life-threatening physical withdrawal symptoms associated with alcohol, benzodiazepines, or opioids. However, their withdrawal can lead to profound exhaustion, severe depression, intense cravings, and, during pregnancy, cardiovascular stress that requires medical attention.

Stimulant stabilization during pregnancy involves a medically monitored setting where sleep, hydration, nutrition, blood pressure, and mental health are closely observed as the drug clears your system. There is currently no FDA-approved MOUD equivalent for stimulants, so treatment focuses on behavioral therapies such as counseling, contingency management, and trauma-informed therapy, integrated with medical oversight and prenatal care.

Polysubstance use (using multiple substances) is common. If you are using opioids and alcohol, or benzodiazepines and methamphetamine, your detox plan will prioritize managing the most dangerous withdrawal first. This often means inpatient 24-hour medical care as per Kansas guidance ⁶, MOUD for opioid components ^{3, 2}, and a stabilization plan for other substances. An honest conversation at intake about all substances used allows the clinical team to develop the most appropriate and safest plan from the outset.

First-Priority Access Under State Law

In Kansas, seeking substance use treatment as a pregnant woman is not asking for a favor; it is exercising a right established by law. Kansas statute K.S.A. 65-1,165 designates pregnant women referred for substance-use treatment as first-priority users of services through the Kansas Department for Aging and Disability Services (KDADS) ¹¹. This means pregnant patients are prioritized over general waiting lists when treatment slots become available. Surrounding statutes (K.S.A. 65-1,163 through 65-1,165) further mandate the state to identify pregnant women at risk, refer them to care, and coordinate services for them and their families ¹¹.

Kansas operationalizes this statute through its perinatal screening guidance, which outlines priority assessment within 24 hours of referral and admission within 48 hours when clinically indicated. This is facilitated through a network of designated women’s substance-use treatment programs, some of which allow children to reside with their mothers in residential care ⁶.

“I am pregnant, and I understand I have priority access under Kansas law.”

Confidentiality and Reporting Requirements

The fear of being reported to child welfare often prevents individuals from seeking help. It’s important to clarify that medical treatment conversations are distinct from child welfare reports. KDHE’s provider workflow instructs clinicians to explain confidentiality and mandated-reporting requirements upfront during the screening process ⁷. This means you have the right to ask, before disclosing any personal information, exactly what the clinician is legally required to report and what will remain confidential within your medical record. They are obligated to provide clear answers.

Additionally, KDHE’s workflow specifies that biological samples (urine, blood) are not required for screening ⁷. Screening typically involves a verbal conversation using a validated tool, not covert drug testing during prenatal appointments. If testing is necessary, you should be informed of its purpose.

Seeking treatment itself does not automatically trigger a child welfare report. In fact, the Kansas system is designed to guide you towards care, not penalize you for seeking it. KDHE’s “Hope Starts Now” campaign actively encourages pregnant and parenting women with substance use issues to reach out, offering a free, anonymous 24/7 Parent Helpline ¹⁰. You can call anonymously before revealing your identity.

While reporting requirements vary by situation and professional role, asking direct questions at the outset is the most effective approach. The key takeaway is that silence does not equate to safety. A clinical team aware of your substance use can effectively protect both you and your baby, whereas an uninformed team cannot.

The First 24 Hours: Screening and Priority Assessment

“I’m pregnant and I think I need help,”

Kansas perinatal screening guidance mandates priority assessment for pregnant patients within 24 hours of referral ⁶. This is a clear operating standard for designated women’s substance-use treatment programs. A clinician, not a receptionist, will conduct an assessment, typically using a validated verbal screening tool rather than a drug test ⁷. You’ll be asked about your substance use patterns—what, how much, how often, and for how long. Providing honest answers helps the team develop a safe and effective plan. There are no hidden traps in this conversation.

You are also encouraged to ask your own questions, such as what information will be documented and what, if anything, must be shared outside the clinical team. KDHE’s workflow directs providers to explain confidentiality and mandated-reporting rules upfront, so these questions are expected ⁷. The first 24 hours are primarily an exchange of information, not a binding commitment or irreversible paperwork.

Admission Within 48 Hours When Clinically Indicated

If your screening indicates a need for inpatient care—most commonly for alcohol, benzodiazepine, opioid, or polysubstance withdrawal—Kansas’s benchmark is admission within 48 hours when clinically indicated ⁶. This is a two-day window, not weeks.

This expedited timeline is supported by K.S.A. 65-1,165, which designates pregnant patients referred for treatment as first-priority users of KDADS services ¹¹. This priority access mechanism significantly shortens typical waitlists. If the first program you contact cannot admit you within this timeframe, they are expected to assist in routing you to another facility that can, rather than simply sending you away.

While it’s helpful to bring identification, insurance information, prenatal records, and a list of current medications, none of these are prerequisites for being seen. Intake teams are accustomed to meeting individuals where they are, and your ability to access care will not be contingent on having all documents in order.

Coordinated Prenatal, Detox, and Continuing Care

Admission marks the beginning, not the entirety, of your medical plan. Safe treatment during pregnancy involves multiple layers of care that operate concurrently.

During the detox phase, this includes physician oversight, nursing staff, medications to manage and prevent withdrawal, and continuous vital-sign monitoring—the inpatient 24-hour medical care recommended by Kansas guidance for alcohol, sedative, and opioid withdrawal ⁶. For opioid use, it means initiating or continuing MOUD, as methadone and buprenorphine are identified by the CDC, SAMHSA, and KDHE as the safer path during pregnancy ^{2, 1}. Your prenatal care will continue uninterrupted. SAMHSA’s whole-person model emphasizes integrating addiction treatment with prenatal, mental health, social, and postpartum services, rather than treating them as separate tasks ⁴.

Following the medically monitored phase, care transitions to a lower intensity, such as residential, partial hospitalization, intensive outpatient, or outpatient programs, along with alumni support, based on your individual needs. Delivery will be planned with your obstetric team, ideally in a hospital setting equipped to observe and treat your newborn for neonatal opioid withdrawal syndrome if necessary ³. The overarching goal across all stages of care is to ensure the safety of both you and your baby, and to connect you with support long enough to establish stability after birth.